The interaction between p145c-KIT and p210bcr-abl in trans-duced cell lines, and the selective outgrowth of normal progenitors during long-term culture of chronic myeloid leukemia (CML) cells on stroma deficient in stem-cell factor (SCF) suggests that the response of CML cells to SCF may be abnormal. We examined the proliferative effect of SCF(100 ng/mL), provided as the sole stimulus, on individual CD341 cells from five normal donors and five chronic-phase CML patients. Forty-eight percent of isolated single CML CD341 cells proliferated after 6 days of culture to a mean of 18 cells, whereas only 8 % of normal CD341 cells proliferated (mean number of cells generated was 4). SCF, as a single agent, supported the survival and expansion of col...
Chronic myeloid leukaemia (CML) is a myeloproliferative disease of stem cell origin, characterised b...
Objective. Transforming growth factor beta(3) (TGF-beta(3)) is a potent suppressor of human hematopo...
We show the molecular and functional characterization of a novel population of lineage-negative CD34...
Normal hematopoiesis is a tightly regulated process involving a balance between signals that stimula...
Stem cell factor (SCF), a c-kit ligand, has a preferential effect on the proliferation of several cl...
A novel hematopoietic growth factor, the stem cell factor (SCF), for primitive hematopoietic progeni...
Chronic myeloid leukemia (CML) is a clonal stem cell disorder that is characterized by the acquired ...
Copyright © 2002 International Society for Experimental Hematology. Published by Elsevier Science In...
Colony-stimulating factor 1 receptor (CSF1R, Fms) is an integral transmembrane glycoprotein with tyr...
Chronic myeloid leukemia (CML) is typified by robust marrow and extramedullary myeloid cell producti...
The aim of this study was to test whether GM-CSF could modulate the response of chronic myeloid leuk...
Recent evidence suggests chronic myeloid leukemia (CML) stem cells are insensitive to kinase inhibit...
Clinical observations suggest that in chronic myelogenous leukemia (CML), the Philadelphia chromosom...
Chronic myeloid leukaemia (CML) is a myeloproliferative disease of stem cell origin, characterised b...
Recent evidence suggests CML stem cells are insensitive to kinase inhibitors and responsible for min...
Chronic myeloid leukaemia (CML) is a myeloproliferative disease of stem cell origin, characterised b...
Objective. Transforming growth factor beta(3) (TGF-beta(3)) is a potent suppressor of human hematopo...
We show the molecular and functional characterization of a novel population of lineage-negative CD34...
Normal hematopoiesis is a tightly regulated process involving a balance between signals that stimula...
Stem cell factor (SCF), a c-kit ligand, has a preferential effect on the proliferation of several cl...
A novel hematopoietic growth factor, the stem cell factor (SCF), for primitive hematopoietic progeni...
Chronic myeloid leukemia (CML) is a clonal stem cell disorder that is characterized by the acquired ...
Copyright © 2002 International Society for Experimental Hematology. Published by Elsevier Science In...
Colony-stimulating factor 1 receptor (CSF1R, Fms) is an integral transmembrane glycoprotein with tyr...
Chronic myeloid leukemia (CML) is typified by robust marrow and extramedullary myeloid cell producti...
The aim of this study was to test whether GM-CSF could modulate the response of chronic myeloid leuk...
Recent evidence suggests chronic myeloid leukemia (CML) stem cells are insensitive to kinase inhibit...
Clinical observations suggest that in chronic myelogenous leukemia (CML), the Philadelphia chromosom...
Chronic myeloid leukaemia (CML) is a myeloproliferative disease of stem cell origin, characterised b...
Recent evidence suggests CML stem cells are insensitive to kinase inhibitors and responsible for min...
Chronic myeloid leukaemia (CML) is a myeloproliferative disease of stem cell origin, characterised b...
Objective. Transforming growth factor beta(3) (TGF-beta(3)) is a potent suppressor of human hematopo...
We show the molecular and functional characterization of a novel population of lineage-negative CD34...